AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1093461 — intervention group
Group type: EXPERIMENTAL
Intervention: radiopharmaceutical imaging technique with 99m-technetium macroaggregated albumin
Number of subjects: 150
Study 1093461 — intervention group
Group type: EXPERIMENTAL
Intervention: perfusion lung study
Number of subjects: 150
Study 31327131 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol 800 mg/day for 40 days
Number of subjects: 62
Study 31327131 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 40 days
Number of subjects: 62
Study 28724799 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 8 mg daily for 4 weeks, followed by 16 mg daily for 8 weeks
Number of subjects: 60
Study 28724799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25239489 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued cognitive-behavior therapy (CBT) for 16 weeks
Number of subjects: 54
Study 25239489 — intervention group
Group type: COMPARATOR
Intervention: Sertraline (SRT) for 16 weeks
Number of subjects: 54
Study 24373281 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 70
Study 24373281 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 70
Study 22115874 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin daily
Number of subjects: 20536
Study 22115874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20536
Study 22115874 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined in-trial and post-trial periods
Number of subjects: 20536
Study 19896079 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab + methylprednisolone (MP)
Number of subjects: 63
Study 19896079 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 63
Study 19896079 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab + MP
Number of subjects: 63
Study 19896079 — intervention group
Group type: COMPARATOR
Intervention: MP
Number of subjects: 63
Study 16827823 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 1200
Study 16827823 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 1200
Study 16827823 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical management
Number of subjects: 1200
Study 16827823 — intervention group
Group type: COMPARATOR
Intervention: All groups (Expectant, Medical, Surgical)
Number of subjects: 1200
Study 15370080 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (betamethasone)
Number of subjects: 17
Study 15370080 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study 10840082 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 19
Study 10840082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 9338926 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroid treated patients
Number of subjects: 85
Study 9338926 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treated patients
Number of subjects: 85
Study 9338926 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient group
Number of subjects: 85
Study 9338926 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression model
Number of subjects: 85
Study 8450996 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (0.75 mg/kg/d)
Number of subjects: 37
Study 8450996 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Prednisone 0.3 mg/kg/d and Azathioprine 2.5 mg/kg/d)
Number of subjects: 37
Study 8450996 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (2.5 mg/kg/d)
Number of subjects: 37
Study 3743416 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 263
Study 3743416 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 263
Study 3743416 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 263
Study 29494867 — intervention group
Group type: EXPERIMENTAL
Intervention: Karolinska Interpersonal Violence Scale (KIVS)
Number of subjects: 106
Study 27184636 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 400 mg twice a day (Group A)
Number of subjects: 250
Study 27184636 — intervention group
Group type: COMPARATOR
Intervention: UDCA 300 mg twice a day (Group B)
Number of subjects: 250
Study 24332892 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 16
Study 24332892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 24332892 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (MPH and placebo)
Number of subjects: 16
Study 23013141 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based brief intervention (web-BI)
Number of subjects: 800
Study 23013141 — intervention group
Group type: COMPARATOR
Intervention: Assessment only control group
Number of subjects: 800
Study 20465444 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevel-up insertion (group 1)
Number of subjects: 60
Study 20465444 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevel-down insertion (group 2)
Number of subjects: 60
Study 20465444 — intervention group
Group type: EXPERIMENTAL
Intervention: MVR blade insertion (group 3)
Number of subjects: 60
Study 17335298 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro (Humalog)
Number of subjects: 0
Study 15821693 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-band RPE
Number of subjects: 28
Study 15821693 — intervention group
Group type: COMPARATOR
Intervention: 2-band RPE
Number of subjects: 28
Study 15821693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both appliances
Number of subjects: 28
Study 12013198 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% glycerin cream
Number of subjects: 197
Study 12013198 — intervention group
Group type: COMPARATOR
Intervention: 4% urea and 4% sodium chloride cream
Number of subjects: 197
Study 12013198 — intervention group
Group type: COMPARATOR
Intervention: cream base without glycerin (placebo)
Number of subjects: 197
Study 10405732 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture at acupoints ST.36 and LI.4
Number of subjects: 18
Study 10405732 — intervention group
Group type: COMPARATOR
Intervention: Control stimulations (minimal acupuncture and superficial pricking)
Number of subjects: 18
Study 7752049 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine stress echocardiography
Number of subjects: 21
Study 7752049 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium-201 (201Tl) scintigraphy with reinjection
Number of subjects: 21
Study 2265339 — intervention group
Group type: EXPERIMENTAL
Intervention: Full silicone catheters
Number of subjects: 77
Study 2265339 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel-coated latex catheters
Number of subjects: 77
Study 2265339 — intervention group
Group type: EXPERIMENTAL
Intervention: Siliconised latex catheters
Number of subjects: 77
Study 475432 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (15-20 mg/kg)
Number of subjects: 37
Study 475432 — intervention group
Group type: COMPARATOR
Intervention: Oral paracetamol (15-20 mg/kg)
Number of subjects: 37
Study 30642528 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-stand workstation plus advice with exercise (n=16)
Number of subjects: 29
Study 30642528 — intervention group
Group type: COMPARATOR
Intervention: Sit-stand workstation plus advice without exercise (n=13)
Number of subjects: 29
Study 28654682 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help (written CBT materials with limited telephone or face-to-face support)
Number of subjects: 473
Study 28654682 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised CBT (cCBT; web-based CBT materials and limited telephone support)
Number of subjects: 473
Study 28654682 — intervention group
Group type: COMPARATOR
Intervention: Waiting list for therapist-led CBT (treatment as usual)
Number of subjects: 473
Study 28654682 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall access to high-intensity CBT
Number of subjects: 473
Study 28654682 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction
Number of subjects: 473
Study 25782585 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper cervical manipulative therapy in addition to a multimodal program
Number of subjects: 120
Study 23886091 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (R group)
Number of subjects: 77
Study 23886091 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus postoperative radiation (SR group)
Number of subjects: 77
Study 23886091 — intervention group
Group type: COMPARATOR
Intervention: Both groups (R and SR)
Number of subjects: 77
Study 21256997 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital ECG utilization with audible voice alarm in the emergency department
Number of subjects: 4219
Study 21256997 — intervention group
Group type: COMPARATOR
Intervention: Standard care (ECG after hospital arrival)
Number of subjects: 4219
Study 21256997 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital ECG utilization
Number of subjects: 4219
Study 19651574 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped intervention (reminder postcards, telephone reminders, intensive case management)
Number of subjects: 811
Study 17519263 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl ITS (40.0 microg fentanyl over 10 min)
Number of subjects: 660
Study 17519263 — intervention group
Group type: COMPARATOR
Intervention: Morphine PCIA (bolus doses for < or =72 h)
Number of subjects: 660
Study 15489847 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (10 mg/day)
Number of subjects: 150
Study 15489847 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 150
Study 11292962 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of alpha tocopherol, rutin, melilotus officinalis, and centella asiatica (oral administration)
Number of subjects: 30
Study 11292962 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study 9733230 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 g fish oil concentrate (6.4 g eicosapentaenoic acid and 3.9 g docosahexaenoic acid)
Number of subjects: 18
Study 9733230 — intervention group
Group type: COMPARATOR
Intervention: 18 g placebo
Number of subjects: 18
Study 8180533 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocal ST depression
Number of subjects: 202
Study 8180533 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated ST depression
Number of subjects: 202
Study 2514324 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 24
Study 2514324 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 24
Study 30075709 — intervention group
Group type: EXPERIMENTAL
Intervention: Attribution retraining combined with exercise class
Number of subjects: 572
Study 30075709 — intervention group
Group type: COMPARATOR
Intervention: Generic health education (control)
Number of subjects: 572
Study 25411324 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse regression approach for handling nonignorable missingness
Number of subjects: 0
Study 25012174 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 75 mg once daily for 6 weeks
Number of subjects: 30
Study 25012174 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone 150 mg once daily for 6 weeks
Number of subjects: 30
Study 25012174 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 20 mg once daily for 6 weeks
Number of subjects: 30
Study 24176099 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemofiltration during bypass (experimental group)
Number of subjects: 37
Study 24176099 — intervention group
Group type: COMPARATOR
Intervention: No haemofiltration during bypass (control group)
Number of subjects: 37
Study 21167341 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 8771
Study 21167341 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex (propensity-matched analysis)
Number of subjects: 8771
Study 19045971 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping and communication-enhancing intervention (CCI)
Number of subjects: 353
Study 19045971 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive counseling (SC)
Number of subjects: 353
Study 19045971 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 353
Study 15983451 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0% end‐tidal sevoflurane (awake state)
Number of subjects: 6
Study 15983451 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% end‐tidal sevoflurane (light state)
Number of subjects: 6
Study 15983451 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% end‐tidal sevoflurane (deep state)
Number of subjects: 6
Study 12771261 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal drug administration
Number of subjects: 8
Study 12771261 — intervention group
Group type: COMPARATOR
Intervention: Intravenous drug administration
Number of subjects: 8
Study 10551650 — intervention group
Group type: COMPARATOR
Intervention: Neoral 5 mg/kg BDS
Number of subjects: 64
Study 10551650 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.05 mg/kg BDS
Number of subjects: 64
Study 8681162 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal orientation session
Number of subjects: 266
Study 8681162 — intervention group
Group type: COMPARATOR
Intervention: Nonoriented subjects
Number of subjects: 266
Study 1948126 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN alpha 2b combined with VBMCP chemotherapy
Number of subjects: 0
Study 1948126 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 0
Study 6832208 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg dose of caffeine as an aqueous oral solution
Number of subjects: 10
Study 6832208 — intervention group
Group type: COMPARATOR
Intervention: 5 mg/kg dose of caffeine as an intravenous infusion
Number of subjects: 10
Study 31378600 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (8 sessions targeting the left dorsolateral prefrontal cortex over 4 weeks)
Number of subjects: 43
Study 31378600 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 43
Study 28948296 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP(3-30)NH2 (800 pmol kg-1 min-1)
Number of subjects: 10
Study 28948296 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP (1.5 pmol kg-1 min-1)
Number of subjects: 10
Study 28948296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 28948296 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP(3-30)NH2 alone
Number of subjects: 10
Study 28948296 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP with or without GIP(3-30)NH2
Number of subjects: 10
Study 26302817 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mL double-balloon catheter
Number of subjects: 98
Study 26302817 — intervention group
Group type: COMPARATOR
Intervention: 30 mL single-balloon catheter
Number of subjects: 98
Study 25015214 — intervention group
Group type: EXPERIMENTAL
Intervention: DSEK
Number of subjects: 63
Study 25015214 — intervention group
Group type: EXPERIMENTAL
Intervention: PK
Number of subjects: 63
Study 25015214 — intervention group
Group type: EXPERIMENTAL
Intervention: DLEK
Number of subjects: 63
Study 25015214 — intervention group
Group type: COMPARATOR
Intervention: All treatments (PK, DLEK, DSEK)
Number of subjects: 63
Study 22354616 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored motivational interviewing intervention
Number of subjects: 16
Study 22354616 — intervention group
Group type: COMPARATOR
Intervention: Delayed control group
Number of subjects: 16
Study 20600555 — intervention group
Group type: COMPARATOR
Intervention: Distilled water immersion for 24 hours at 37 degrees C (baseline measurement)
Number of subjects: 114
Study 20600555 — intervention group
Group type: EXPERIMENTAL
Intervention: Distilled water immersion for 1 week, 1 month, or 3 months at 37 degrees C or 60 degrees C
Number of subjects: 114
Study 20600555 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01 mol/L lactic acid immersion for 1 week, 1 month, or 3 months at 37 degrees C or 60 degrees C
Number of subjects: 114
Study 20600555 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% ethanol immersion for 1 week, 1 month, or 3 months at 37 degrees C or 60 degrees C
Number of subjects: 114
Study 20600555 — intervention group
Group type: EXPERIMENTAL
Intervention: Nexus 2 and Rely X Veneer
Number of subjects: 114
Study 20600555 — intervention group
Group type: EXPERIMENTAL
Intervention: Rely X Luting 2
Number of subjects: 114
Study 20600555 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin luting cements vs RM-GICs
Number of subjects: 114
Study 20600555 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia F and Set vs RM-GICs
Number of subjects: 114
Study 17469693 — intervention group
Group type: COMPARATOR
Intervention: Cholinesterase inhibitors (e.g., rivastigmine, donepezil)
Number of subjects: 0
Study 17469693 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study 17469693 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 17310311 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CPAP and 100 mg sildenafil on demand for intercourse
Number of subjects: 40
Study 17310311 — intervention group
Group type: COMPARATOR
Intervention: CPAP alone
Number of subjects: 40
Study 17310311 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CPAP and sildenafil
Number of subjects: 40
Study 14499676 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guerin (BCG) instillations
Number of subjects: 487
Study 11218623 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon + N-acetyl cysteine
Number of subjects: 77
Study 11218623 — intervention group
Group type: COMPARATOR
Intervention: Interferon alone
Number of subjects: 77
Study 9112881 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2-enriched water (1200 mg CO2 per kg water; immersion time, twenty minutes)
Number of subjects: 18
Study 9112881 — intervention group
Group type: COMPARATOR
Intervention: Fresh water (immersion time, twenty minutes)
Number of subjects: 18
Study 1589232 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (up to 8 mg in 20 ml vehicle)
Number of subjects: 20
Study 1589232 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 20
Study 1589232 — intervention group
Group type: EXPERIMENTAL
Intervention: Both naloxone and saline
Number of subjects: 20
Study 1589232 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 20
Study 3916511 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (azathioprine and prednisone)
Number of subjects: 32
Study 3916511 — intervention group
Group type: COMPARATOR
Intervention: Group II (cyclosporine and prednisone)
Number of subjects: 32
Study 31752938 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel trauma score (0-14 points based on age, Glasgow Coma Scale, systolic blood pressure, and respiratory rate)
Number of subjects: 99767
Study 31752938 — intervention group
Group type: COMPARATOR
Intervention: Revised Trauma Score (RTS)
Number of subjects: 99767
Study 31752938 — intervention group
Group type: COMPARATOR
Intervention: Mechanism, Glasgow Coma Scale, Age, and Arterial Pressure (MGAP) score
Number of subjects: 99767
Study 29453924 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO criteria
Number of subjects: 520
Study 29453924 — intervention group
Group type: COMPARATOR
Intervention: IADPSG criteria
Number of subjects: 520
Study 25969342 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led case management intervention
Number of subjects: 12181
Study 25969342 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 12181
Study 25593907 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal photopheresis (ECP) administered two consecutive days twice a month
Number of subjects: 20
Study 25593907 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A (CsA) at a dosage of 3 mg/kg/day
Number of subjects: 20
Study 22135107 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferring word meanings with English feedback
Number of subjects: 0
Study 22135107 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferring word meanings with German feedback
Number of subjects: 0
Study 22135107 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferring word meanings with no feedback
Number of subjects: 0
Study 22135107 — intervention group
Group type: EXPERIMENTAL
Intervention: Using marginal glosses
Number of subjects: 0
Study 22135107 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferring word meanings with feedback in English vs. German
Number of subjects: 0
Study 20562693 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma B-type natriuretic peptide and N-terminal fragment of its pro-hormone concentrations
Number of subjects: 1016
Study 20562693 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher plasma B-type natriuretic peptide and N-terminal fragment of its pro-hormone concentrations
Number of subjects: 1016
Study 18557810 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb botulinum toxin-A therapy (UL BTX-A)
Number of subjects: 22
Study 18557810 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 16019553 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine)
Number of subjects: 476
Study 16019553 — intervention group
Group type: EXPERIMENTAL
Intervention: EBVD (epirubicin instead of doxorubicin)
Number of subjects: 476
Study 16019553 — intervention group
Group type: EXPERIMENTAL
Intervention: MBVD (mitoxantrone instead of doxorubicin)
Number of subjects: 476
Study 12066724 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 100 mg before induction of anaesthesia (group 1)
Number of subjects: 17
Study 12066724 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 2)
Number of subjects: 17
Study 10520501 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin or its analogs
Number of subjects: 0
Study 10520501 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreaticojejunostomy
Number of subjects: 0
Study 10520501 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreaticogastrostomy
Number of subjects: 0